期刊论文详细信息
Perspectives in Clinical Research | |
Drug lag and key regulatory barriers in the emerging markets | |
关键词: Drug lag; BRIC countries; N-11 countries; Emerging Markets; Marketing authorisation; Regulatory barriers; | |
DOI : | |
来源: DOAJ |
【 授权许可】
Unknown